Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RETAP study of angiotensin II response in formerly preeclamptic women
NL-OMON36569Not yet recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Jan 2011
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Open-label trial of Angiotensin II (2 arms), sponsored by University Medical Center Groningen. Primary endpoints: Renal response to angiotensin II after low and high sodium diet and Systemic blood pressure response to angiotensin II after low and high sodium diet. Planned start Jan 2011; status: not yet recruiting.
02
Drugs
Angiotensin II
Beyond the preview
Go deeper on NL-OMON36569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36569.